X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare Abbott India with ALEMBIC PHARMA - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ABBOTT INDIA vs ALEMBIC PHARMA - Comparison Results

ABBOTT INDIA    Change

Formerly known as Knoll Pharmaceuticals Limited, Abbott India Limited (AIL) is a subsidiary of Abbott Capital India Limited in which the latter holds about 69% stake. It is involved in the discovery, development, manufacture and marketing of pharmace... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    ABBOTT INDIA ALEMBIC PHARMA ABBOTT INDIA/
ALEMBIC PHARMA
 
P/E (TTM) x 35.7 20.9 171.1% View Chart
P/BV x 10.3 5.5 188.3% View Chart
Dividend Yield % 0.6 0.9 69.1%  

Financials

 ABBOTT INDIA   ALEMBIC PHARMA
EQUITY SHARE DATA
    ABBOTT INDIA
Mar-17
ALEMBIC PHARMA
Mar-16
ABBOTT INDIA/
ALEMBIC PHARMA
5-Yr Chart
Click to enlarge
High Rs5,190792 655.6%   
Low Rs4,351443 982.2%   
Sales per share (Unadj.) Rs1,382.9167.0 828.0%  
Earnings per share (Unadj.) Rs130.238.2 341.1%  
Cash flow per share (Unadj.) Rs137.942.0 328.4%  
Dividends per share (Unadj.) Rs40.004.00 1,000.0%  
Dividend yield (eoy) %0.80.6 129.4%  
Book value per share (Unadj.) Rs652.784.9 768.8%  
Shares outstanding (eoy) m21.25188.52 11.3%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x3.43.7 93.3%   
Avg P/E ratio x36.616.2 226.5%  
P/CF ratio (eoy) x34.614.7 235.3%  
Price / Book Value ratio x7.37.3 100.5%  
Dividend payout %30.710.5 293.1%   
Avg Mkt Cap Rs m101,373116,383 87.1%   
No. of employees `0003.1NA-   
Total wages/salary Rs m3,4534,214 81.9%   
Avg. sales/employee Rs Th9,531.9NM-  
Avg. wages/employee Rs Th1,119.9NM-  
Avg. net profit/employee Rs Th897.3NM-  
INCOME DATA
Net Sales Rs m29,38731,487 93.3%  
Other income Rs m57655 1,046.1%   
Total revenues Rs m29,96331,542 95.0%   
Gross profit Rs m3,97310,060 39.5%  
Depreciation Rs m164722 22.8%   
Interest Rs m2037 55.4%   
Profit before tax Rs m4,3659,356 46.7%   
Minority Interest Rs m00-   
Prior Period Items Rs m0-2 0.0%   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m1,5982,160 74.0%   
Profit after tax Rs m2,7677,194 38.5%  
Gross profit margin %13.531.9 42.3%  
Effective tax rate %36.623.1 158.6%   
Net profit margin %9.422.8 41.2%  
BALANCE SHEET DATA
Current assets Rs m18,90615,066 125.5%   
Current liabilities Rs m6,2977,674 82.0%   
Net working cap to sales %42.923.5 182.8%  
Current ratio x3.02.0 152.9%  
Inventory Days Days6267 92.9%  
Debtors Days Days2241 53.3%  
Net fixed assets Rs m1,1598,237 14.1%   
Share capital Rs m213377 56.4%   
"Free" reserves Rs m13,65715,416 88.6%   
Net worth Rs m13,86916,005 86.7%   
Long term debt Rs m00-   
Total assets Rs m20,63824,594 83.9%  
Interest coverage x215.0255.2 84.2%   
Debt to equity ratio x00-  
Sales to assets ratio x1.41.3 111.2%   
Return on assets %13.529.4 45.9%  
Return on equity %19.944.9 44.4%  
Return on capital %31.658.7 53.9%  
Exports to sales %055.7 0.0%   
Imports to sales %010.4 0.0%   
Exports (fob) Rs mNA17,551 0.0%   
Imports (cif) Rs mNA3,283 0.0%   
Fx inflow Rs m017,811 0.0%   
Fx outflow Rs m05,318 0.0%   
Net fx Rs m012,493 0.0%   
CASH FLOW
From Operations Rs m3,0729,304 33.0%  
From Investments Rs m-1,554-3,105 50.1%  
From Financial Activity Rs m-898-1,959 45.8%  
Net Cashflow Rs m6214,240 14.6%  

Share Holding

Indian Promoters % 0.0 74.1 -  
Foreign collaborators % 75.0 0.0 -  
Indian inst/Mut Fund % 7.9 2.9 272.4%  
FIIs % 0.1 9.1 1.1%  
ADR/GDR % 0.0 0.0 -  
Free float % 17.1 13.9 123.0%  
Shareholders   18,270 49,328 37.0%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare ABBOTT INDIA With:   GSK PHARMA  NATCO PHARMA  DIVIS LABORATORIES  PIRAMAL ENTERPRISES  ALKEM LABORATORIES  

Compare ABBOTT INDIA With:   MYLAN (US)  ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Of Cheap Valuation of PSU Banks and Key Stocks in Action Today(Pre-Open)

NSE PSU Bank Index surged 30% on 25th October 2017-the date when bank recapitalization of Rs 2.1 trillion was announced.

Related Views on News

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

Dr Reddy's: Milestone Payment Drives Sales (Quarterly Results Update - Detailed)

Feb 9, 2018

US business was hit by pricing pressure although there was growth sequentially led by new product launches.

Lupin: US market Declines Due to Higher Base Effect of FY17 (Quarterly Results Update - Detailed)

Feb 9, 2018

Price erosion in generic US drugs continues but seems to be bottoming out.

Biocon: US Pricing Pressure Takes Toll (Quarterly Results Update - Detailed)

Feb 2, 2018

Pricing pressure in the US and costs of the Malaysian facility hit Biocon's profits in the third quarter.

Shalby Ltd. (IPO)

Dec 2, 2017

Should you subscribe to the IPO of Shalby Ltd?

More Views on News

Most Popular

My Top Five Stocks After the Karnataka Elections(The 5 Minute Wrapup)

May 16, 2018

The markets seem confused. They're neither going up nor down. What should investors do? Consider Safe Stocks. Here's the top 5 Safe Stocks in the market today.

How A Storm Destroyed Rain Industries... And a Superb Small Cap Stock I Recommend(Profit Hunter)

May 17, 2018

A mutual fund regulation could cause small cap prices to tank - If you haven't been paying attention to your small caps - now is the time to catch the opportunities that start pouring in.

Has the Indian Home Buyer Become Smarter?(Vivek Kaul's Diary)

May 17, 2018

Home loans continue to grow, despite falling sales. What explains this phenomenon?

Looking Beyond the Colourful Prism of This Airline Company(Sector Info)

May 10, 2018

Can Interglobe Aviation Safely Fly Out of Turbulence?

HDFC Prudence Fund Now HDFC Balanced Advantage Fund - Time To Sell?(Outside View)

May 9, 2018

PersonalFN provides detail analysis on HDFC Balanced Advantage Fund (erstwhile HDFC Prudence Fund and HDFC Growth Fund).

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

ABBOTT INDIA SHARE PRICE


May 18, 2018 (Close)

TRACK ABBOTT INDIA

  • Track your investment in ABBOTT INDIA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

ABBOTT INDIA 8-QTR ANALYSIS

COMPARE ABBOTT INDIA WITH

MARKET STATS